IQVIA Institute for Human Data Science -
This annual report examines novel medicines and the clusters of research, which promise a continuing sequence of breakthroughs in the decade to come. The report explores the impact of Covid-19 disruptions and the longer-term trends in the use of cancer medicines as well as the drivers of spending globally, in key geographies, by tumor type, and for specific types of oncology drugs. Please note that free registration is required to access the report.